Urticaria | Platelet Activation in Chronic Inflammatory Skin Diseases
Urticaria research study
What is the primary objective of this study?
Platelets are blood cells that are important in coagulation of the blood. These cells have
recently been shown to play a role in a number of other biologic processes, for example
inflammation. In this study the investigators will determine the extent of platelet
activation in people suffering from common chronic skin inflammation-urticaria and allergic
Who is eligible to participate?
Inclusion Criteria: Urticaria or atopic dermatitis -
Exclusion Criteria:Lack of informed consent
Which medical condition, disease, disorder, syndrome, illness, or injury is researched?
Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.
Procedure:Blood samplingBlood sampling
Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.
Skin diseasePatients with urticaria or atopic dermatitis
Start Date: February 2013
Completed Date: October 2013
Primary Outcome: Platelet activation
Secondary Outcome: Mean platelet volume
Study sponsors, principal investigator, and references
Lead Sponsor: Meir Medical Center